Highlights: -Are “off-the-shelf” fenestrated endografts seeing a new dawn? -Lower restenosis and re-occlusion rates with drug-eluting balloons compared to angioplasty in DEBATE-BTK -Dismantling the different myths around the CREST trial -Profile: Patrick Peeters
